Clinical Evaluation of Bioactive Injectable Resin Composite in Posterior Restorations

NCT ID: NCT05499494

Last Updated: 2022-08-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

26 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-08-31

Study Completion Date

2024-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the study is to evaluate the clinical performance of new bioactive injectable composite compared to nanohybrid composite during the restoration of posterior cavities

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Statement of the problem:

Marginal defects of composite fillings are often thought to be caused by poor adaptation of the restorative material to the cavity wall. To avoid these defects, particularly in posterior teeth, the use of flowable composites has been advocated because of their ability to 'wet' and adapt well to cavity margins and walls. However, flowable composites have a lower filler content and usually weaker mechanical properties than conventional composites.

The continued development of resin composites has led to formulations designed to further simplify the filling procedure, provide better mechanical properties, reduce the effect of polymerization shrinkage stresses and improve aesthetics. Recently, a new type of highly filled flowable composite has been developed. It is characterized by its high viscosity and is claimed to have improved mechanical properties not dissimilar from conventional composite restorative materials. This composite contains nano-sized filler particles, and due to its consistency, the material has been referred to as an 'injectable composite'.

Rationale for carrying out the trial:

The rationale of this study is to evaluate the mechanical performance of injectable composite resin against nanohybrid composites, because of its easy handling, time-saving, better margin adaptation, and the gain of extra mechanical properties at the same time.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dental Restoration Failure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

injectable composite

The material will be applied according to manufacturer instructions. BEAUTIFIL Flow Plus X will be applied directly into the cavity and create the shape desired in layers not exceeding 2 mm, and light cured for 20 seconds.

Group Type EXPERIMENTAL

Beautifil Flow Plus X F00 injectable composite

Intervention Type OTHER

bioactive injectable composite

Nanohybrid resin composite

The nanohybrid resin composite will be applied to the the cavity using the conventional incremental technique according to manufacturer instructions.

Group Type ACTIVE_COMPARATOR

Tetric N ceram resin composite

Intervention Type OTHER

Nano hybrid resin composite

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Beautifil Flow Plus X F00 injectable composite

bioactive injectable composite

Intervention Type OTHER

Tetric N ceram resin composite

Nano hybrid resin composite

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Participants:

1. Age range 20-50 years.
2. Males Or females .
3. Co-operative patients approving to participate in the trial.
* Teeth:

1. class I or II carious lesions premolars and molars.
2. Vital upper or lower teeth with no signs of irreversible pulpitis and pulpal necrosis.
3. Presence of favorable occlusion and teeth are in normal contact with the adjacent teeth.

Exclusion Criteria

* Participants:

1. Patients with general systemic illness.
2. Allergic history against any component of used material.
3. Disabilities.
4. Pregnancy
5. Xerostomia.
6. Lack of compliance.
7. Evidence of parafunctional habits.
8. Temporomandibular joint disorders.
* Teeth:

1. Periapical pathology or signs of pulpal pathology.
2. Endodontically treated teeth.
3. Tooth hypersensitivity.
4. Possible prosthodontic restoration of teeth.
5. Heavy occlusion and occlusal contacts or history of bruxism.
6. Severe periodontal affection.
Minimum Eligible Age

20 Years

Maximum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Cairo University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Hazem Mohamed El Deriny

Assistant lecturer at operative dentistry

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mai Mamdouh, PhD

Role: STUDY_DIRECTOR

Cairo University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Faculty of dentistry, Cairo University

Cairo, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Hazem Elderiny, M.SC

Role: CONTACT

+201007775636

Yomna Khallaf, PhD

Role: CONTACT

+201006781076

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Mai Mamdouh, PhD

Role: primary

+201066444572

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Injectable resin composite

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.